Search clinical trials for: Amgen, etanercept

Total 456 results

University of Aarhus
AbbVie; Aarhus University Hospital; Aage Bangs Fond; Region Midt Forskningsfond

Completed

Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

Atherosclerosis | Psoriasis | Atopic Dermatitis

Denmark
University of Michigan Rogel Cancer Center

Completed

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

Bronchiolitis Obliterans | Respiratory Distress Syndrome, Adult | Lung Injury, Acute

United States
Haukeland University Hospital

Terminated

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis

Norway
Spanish Clinical Pharmacology Society
Spanish reumatology Society

Completed

Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF (REDES-TNF)

Spondylarthropathies

Spain
Amgen

Completed

Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects

Healthy Men and Women
Pfizer

Completed

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes (EMBARK)

Spondylitis, Ankylosing

Belgium, Korea, Republic of, Spain, France, Taiwan, Germany, Argentina, Czech Republic, United Kingdom, Hungary, Russian Federation, Colombia, Finland, Netherlands
Japan Biological Agent Study Integrated Consortium

Completed

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (JESMR)

Rheumatoid Arthritis

Japan
Biogen
Hoffmann-La Roche; Genentech, Inc.

Terminated

Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Assistance Publique Hopitaux De Marseille

Completed

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

Rheumatoid Arthritis | Psoriatic Arthritis | Inflammatory Rheumatism

France
Glostrup University Hospital, Copenhagen

Terminated

Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis (SPARTA)

SPONDYLOARTHRITIS

Denmark
Pfizer

Completed

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (PRESERVE)

Arthritis, Rheumatoid

Czech Republic, Colombia, Germany, France, Belgium, Spain, Russian Federation, Poland, Australia, Austria, Chile, Former Serbia and Montenegro, Hungary, Italy, Korea, Republic of, Mexico, Netherlands, Sweden, Taiwan, United Kingdom
Pfizer

Completed

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Psoriasis

Germany
Fundación Pública Andaluza Progreso y Salud

Completed

Etanercept Survival in Elderly Population

Psoriasis

Spain
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
Ludwig Institute for Cancer Research
Johns Hopkins University

Withdrawn

Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

Solid Tumors | Lymphomas

Germany
Massachusetts General Hospital
Brigham and Women's Hospital; Stanford University

Completed

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Pemphigus Vulgaris

United States
University of Utah

Withdrawn

Etanercept for the Treatment of Chronic Urticaria (EtanerceptCIU)

Chronic Idiopathic Urticaria

United States
Merck Sharp & Dohme LLC

Withdrawn

A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

Rheumatoid Arthritis
University of Glasgow
NHS Lothian; NHS Tayside; NHS Grampian; Arthritis Research UK; NHS Fife; NHS Borders

Completed

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy (ORBIT)

Rheumatoid Arthritis

United Kingdom
Chung Shan Medical University

Unknown

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Taiwan
Pfizer

Completed

Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Germany
Janssen Biotech, Inc.
Merck Sharp & Dohme LLC

Completed

Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

Autoimmune Diseases | Arthritis | Arthritis, Rheumatoid

United States, United Kingdom, Belgium, Greece, Canada, Germany, Sweden, Austria
Stiefel, a GSK Company
GlaxoSmithKline

Withdrawn

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Plaque Psoriasis

United States
FDA Office of Orphan Products Development

Completed

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

Pneumonia | Bronchiolitis Obliterans | Respiratory Distress Syndrome, Adult

United States
Medical University of Vienna

Completed

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Inflammatory Bowel Diseases | Psoriasis
University of Medicine and Dentistry of New Jersey
Connetics Corp.

Completed

Acitretin and Etanercept in Psoriasis

Psoriasis
LG Life Sciences

Completed

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Healthy

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)

Psoriasis
Emory University
Amgen

Completed

Etanercept and Vascular Function in Psoriasis (EVIP)

PSORIASIS

United States
Pfizer

Completed

Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. (AS@WORK)

Ankylosing Spondylitis

Belgium
University of Aberdeen
NHS Grampian

Completed

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Psoriasis

United Kingdom
National Institute of Environmental Health Sciences...

Completed

Functional Implications of TNF

Bronchitis

United States
Virginia Commonwealth University
University of Miami

Withdrawn

Islet After Kidney Transplant for Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Pfizer

Completed

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (Enbrel-JIA)

Juvenile Idiopathic Arthritis

Japan
Pfizer

Completed

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

Rheumatoid Arthritis
Pfizer

Completed

Observational Trial With Enbrel

Rheumatoid Arthritis

Germany
Pfizer

Completed

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis (SPARSE)

Axial Spondyloarthritis

France
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Psoriasis
Innovaderm Research Inc.
Amgen

Completed

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Psoriasis

Canada
Amgen

Completed

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Psoriasis
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

CAMEO: Canadian Methotrexate and Etanercept Outcome Study

Rheumatoid Arthritis

Canada
Pfizer

Completed

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

Active Rheumatoid Arthritis | Arthritis, Rheumatoid | Rheumatoid Arthritis

Italy, Spain, Switzerland, France, Germany, Poland, Netherlands, United Kingdom, Monaco, Romania, Ireland, Qatar, Russian Federation
University of Alabama at Birmingham
Pfizer; Amgen; Barr Laboratories

Completed

Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) (TEAR)

Rheumatoid Arthritis

United States
Hanwha Chemical

Completed

Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients

Rheumatoid Arthritis

Korea, Republic of
Pfizer

Completed

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria (BEFLEX)

Plaque Psoriasis Patients

Belgium
Pfizer

Completed

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis (CLIPPER)

Arthritis, Juvenile Idiopathic

France, Spain, Serbia, Belgium, Germany, Czech Republic, Colombia, Mexico, Russian Federation, Norway, Italy, Slovenia, Slovakia, Poland, Australia, Hungary, Latvia, Lithuania, Netherlands
Washington University School of Medicine
Amgen

Completed

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

Inclusion Body Myositis

United States
Jagiellonian University
Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland

Unknown

Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Hypertension | Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Poland
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)

Psoriatic Arthritis
University of Southampton
Wyeth is now a wholly owned subsidiary of Pfizer; Hampshire Hospitals NHS Foundation...

Completed

Safety and Tolerability of Etanercept in Alzheimer's Disease (STEADI-09)

Alzheimer's Disease

United Kingdom

Search clinical trials for: Amgen, etanercept

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations